Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge
about
Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesNeutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorSurvivors Remorse: antibody-mediated protection against HIV-1.Current views on the potential for development of a HIV vaccine.Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine RegimensWhich Antibody Functions are Important for an HIV Vaccine?Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmissionEnhanced neonatal Fc receptor function improves protection against primate SHIV infection.A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice.Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" processNeutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cellsThe maturation of antibody technology for the HIV epidemic.Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.Non-Neutralizing Antibodies Directed against HIV and Their Functions.Advances in HIV-1 Vaccine Development.Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
P2860
Q27318508-4A1E090E-7315-4B49-A4B8-B95E8F6ED06DQ27684529-FBBFDE1C-CA68-4E29-9657-A4C0BB28E455Q30238730-9050B2F8-2E69-4780-BE1F-24F8A6AEEB5AQ30397595-124F23D7-04A0-4F29-9892-513A3BDE8514Q33638320-52993272-024F-4763-9EC2-5CB67C48C84DQ33720317-CF0BFA21-1459-42F6-9F52-AF46AEA65551Q33772637-C52DBB77-CFE6-4335-9DEE-3FD7B61B5D3EQ35488153-CA2526BC-70EB-4998-8F52-25F0D489930BQ35612850-27E6B497-3577-4E60-852E-0A3A9125735BQ35667426-B7326BB2-A2BC-44ED-8A58-A875EC8AC351Q36012177-C285E0DF-FF7B-47E4-AD46-3931E2240F4DQ36257975-1B7C437E-EB4E-425E-8ECF-C09087489203Q36288959-F94770A0-ABB6-4434-89B0-A2C3725EC338Q37025857-C0B3DEAB-7A8F-4B2D-9053-8449670DCDF4Q37499531-B72898D9-CC1E-4DDF-A7F6-A519EDE234EDQ37510242-72FCFD76-CD2F-4BAD-A0EF-8DDE9E29BDCDQ37512871-D54C0291-CC70-41D0-AC29-E0F0361660D5Q37713968-F7479CF2-F2DA-4D46-95D7-CEC7F9530D9AQ38209477-CC09FEFA-44BE-42C3-A078-8728D92A2347Q38688524-320BAB14-A4B4-42CB-BC57-02B7E079273AQ40047250-0B96193D-DE64-460E-8E5E-C4DC66F3ABC4Q47139556-483E97BA-9C04-465C-AF27-49DECB12A0ECQ52609661-C60232E1-090C-40A2-86E3-69B4A83D2430Q58724429-71713C51-013D-4E89-A253-0498B53A734F
P2860
Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neutralizing IgG at the portal ...... munodeficiency virus challenge
@en
Neutralizing IgG at the portal ...... unodeficiency virus challenge.
@nl
type
label
Neutralizing IgG at the portal ...... munodeficiency virus challenge
@en
Neutralizing IgG at the portal ...... unodeficiency virus challenge.
@nl
prefLabel
Neutralizing IgG at the portal ...... munodeficiency virus challenge
@en
Neutralizing IgG at the portal ...... unodeficiency virus challenge.
@nl
P2093
P2860
P50
P356
P1433
P1476
Neutralizing IgG at the portal ...... munodeficiency virus challenge
@en
P2093
Hua-Xin Liao
Katja Klein
Lara A Doyle-Meyers
Ranjit Warrier
Ronald S Veazey
Viviana Buffa
P2860
P304
11604-11616
P356
10.1128/JVI.01361-13
P407
P577
2013-08-21T00:00:00Z